VBI Vaccines Inc. (VBIV) Comparison with companies in other sectors?

VBI Vaccines Inc. has a share price of 28.68M. You can analyze VBI Vaccines Inc. (VBIV) competitors across different market sectors through stock heatmaps.

What are VBIV's NET and operating margins?

VBI Vaccines Inc. (VBIV) operating margin is around -11.67, and net profit margin is approximately -8.67 as of the latest reports.

In what way does VBIV's earnings per share (EPS) trend reflect its financial momentum?

VBI Vaccines Inc. (VBIV) EPS is -3.54 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for VBI Vaccines Inc. is -0.02, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for VBI Vaccines Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for VBI Vaccines Inc. like P/E which is -0.09, P/B which is -0.29, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

VBI Vaccines Inc.

VBIV•NASDAQ

Healthcare

Biotechnology

$0.07

$-0.07(-50.87%)

Fundamental Analysis of VBI Vaccines Inc. (VBIV)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-3.54

P/E Ratio

-0.02

ROE

-17.39%

Net Margin

-8.67%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.87M

Shares OutstandingTotal number of shares issued

$28.68M

Book Value/ShareNet worth per share

$-0.22

Revenue/ShareAnnual revenue per share

$0.08

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-3.54

Net MarginNet income as percentage of revenue

-866.62%

Operating MarginOperating income as percentage of revenue

-1166.72%

ROEReturn on shareholders' equity

-1739.13%

ROAReturn on total assets

-23.74%

ROCEReturn on capital employed

1121.15%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.95

Cash/ShareCash and equivalents per share

$0.51

FCF YieldFree cash flow as percentage of market cap

-1248.35%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for VBIVFinancial Ratios Analysis details for VBIV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for VBIVSector Benchmarking details for VBIV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for VBI Vaccines Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of VBI Vaccines Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account VBI Vaccines Inc.'s unique business strengths and challenges.

Key Financial Metrics for VBI Vaccines Inc.

For VBI Vaccines Inc., essential financial indicators include EPS -3.54, PE -0.02, and ROE -17.39. These key ratios reveal insights into VBI Vaccines Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare VBI Vaccines Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of VBI Vaccines Inc.

Metrics like Net Margin -866.62% and ROA -23.74% shed light on how well VBI Vaccines Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether VBI Vaccines Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of VBI Vaccines Inc.

Using ratios such as P/B Ratio -0.29 and PEG Ratio -0.00, investors can assess whether VBI Vaccines Inc. is appropriately valued based on its financials and growth potential. These figures, combined with VBI Vaccines Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for VBI Vaccines Inc.

Financial health indicators, such as Debt/Equity Ratio -9.28 and Cash Flow $-0.95, provide a snapshot of VBI Vaccines Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like VBI Vaccines Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for VBI Vaccines Inc.

Investing in VBI Vaccines Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at VBI Vaccines Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;